EMERYVILLE, CA – May 17, 2012 – NovaBay Pharmaceuticals, Inc. (NYSE AMEX: NBY), a clinical-stage biotechnology company developing novel anti-infective products for the treatment and prevention of topical infections, today announced that it has enrolled the first patients in its global Phase 2b clinical study. The study (named BAYnovationTM) will evaluate the Company’s lead compound, …

A drive to improve quality, yield, and cycle time coupled with desire for high personal performance has led to novel chemistry methodologies enabling a wide range of reactions in product development. A METTLER TOLEDO white paper explores the interrelationship of two of these critical methodologies, flow chemistry and mid-infrared spectroscopy, in today’s highly competitive R&D …

Whilst the introduction of lasers in laryngeal surgery has enabled major evolutions in surgical techniques, the control of the smoke plume has historically been a challenge.  To solve this problem surgeons at The Royal Hallamshire Hospital and Single Use Surgical (SUSL) have developed a simple, efficient way to evacuate surgical smoke.   A cleverly designed …

Abingdon, United Kingdom, May 21 2012 – Isansys Lifecare Limited, the provider of complete real-time physiological patient data services and systems, today announces the introduction of its Patient Status Engine™ – the first cloud-based patient digitization and analytic solution for monitoring and predicting the present and future clinical status of patients anytime, anywhere. The introduction …

SAN DIEGO – May 14, 2012 (Investorideas.com newswire) – Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chairman and CEO James A. Joyce will present at today’s Security Research Associates (SRA) 8th Annual Growth Stock Conference. The Conference will be held at the Le Meriden Hotel in San Francisco. A live webcast of the presentation will …

 Nominations are invited from hospitals in india for the public poll “Hospital of the Year 2012”, the first of its kind to be live on the website www.HospitalExplorer.in HospitalExplorer is hosting “Hospital of the year 2012” at www.HospitalExplorer.in . Patients, Doctors, Staff and any internet user can cast their vote for any hospital. Nominations are …

ShelfGenie, announced this week an offer to match 100 percent of every donation up to $250 per donation made by ShelfGenie employees, franchisees, designers, installers, suppliers and friends as part of its mission to raise $25,000 for the Juvenile Diabetes Research Foundation Ride to Cure Diabetes. Marietta, GA (USA), May 13, 2012 – ShelfGenie® ( …

Mumbai, India, May 11th, 2012: Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards (IFRS). Key Highlights oConsolidated revenues at `96.7 billion in FY12, year-on-year growth of 30%, driven by key markets of North America and …

New York, New York – May 11, 2012 – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Arena Pharmaceuticals, Inc. (NasdaqGS:ARNA) making big moves, gaining $5.82 2.16(59.02%) 10:51AM EDT on over 40 million shares in morning trading . The stock was up over 80% …

Denham Springs, LA – Narconon Riverbend Retreat Louisiana is proud to lend its support to Project Graduation with a cash donation and drug education DVDs.  On Friday, May 11, 2012, the Senior Class of Denham Springs High School will hold its 10th annual graduation which will be followed by Project Graduation from 11:00 p.m. to …

SAN DIEGO – May 8, 2012 (Investorideas.com newswire) – Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, reported today that the presence of Hepatitis C virus (HCV) is currently undetectable in all infected patients that have been treated with the Aethlon …

Denham Springs, LA – Narconon Riverbend Retreat Louisiana actively supports the National Council on Alcoholism and Drug Dependence and National Alcohol Awareness Month.  In keeping with this year’s theme, “Healthy Choices, Healthy Communities:  Prevent Underage Drinking”, Narconon Riverbend is spotlighting a graduate of the Narconon program who overcame alcoholism. Mothers Against Drunk Driving reports that …

Boston, MA ( your-story.org ) May 2, 2012 – Dr. William P. Adams of The Adams Center of Boston and Peabody announced he will be attending The American Society for Aesthetic Plastic Surgery’s 2012 Aesthetic Meeting held in Vancouver, British Columbia in May.  The Aesthetic Meeting is the premier aesthetic surgery conference featuring educational exhibits, …

MadgeTech, Inc. will be exhibiting at the Interphex exhibition from May 1st through the 3rd in New York, New York. The show features a full spectrum of products and services for the pharmaceutical and biopharmaceutical industries. MadgeTech will be highlighting the PR140, HiTemp140 and Therm•A•lert data logging systems. The PR140 is a pressure data logger …

Spring Hill, FL – Suncoast Rehabilitation Center took their Narconon Alcohol and Drug Rehab Program information to the National RX Drug Abuse Summit held in Orlando, FL, April 10th through the 12th, 2012. Over 700 participants from around the country met to address the prescription drug abuse epidemic. The conference programming featured thought-provoking presentations by …

DELRAY BEACH, Fla. – April 25, 2012 (Investorideas.com newswire) – PositiveID Corporation’s (OTCBB:PSID) iglucose was named a finalist in the Healthcare and Wellness Category of CTIA’s annual Emerging Technology (E-Tech) Awards competition. The CTIA E-Tech Awards honor the most innovative new products in 15 categories spanning the areas of mobile apps, consumer electronics, enterprise and …

Pharmaceutical and biotechnology major Wockhardt has launched an authorized generic version of four strengths (50mg, 75mg, 125mg and 200mg) of the triple-drug combination product containing Levodopa, Carbidopa and Entacapone, which are used in treatment of Parkinson’s disease. The Levodopa + Carbidopa + Entacapone tablet is the generic name for the brand Stalevo®, owned by Orion …

DELRAY BEACH, Fla. – April 19, 2012 (Investorideas.com newswire) – PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense, today announced its FDA-cleared iglucose(R) mobile health system for diabetes management will be featured at the CTIA Emerging …

EMERYVILLE, Calif., April 16, 2012 (GLOBE NEWSWIRE) — NovaBay(R) Pharmaceuticals, Inc. (NYSE AMEX:NBY), a biotech company developing novel anti-infective products for the treatment and prevention of microbial infections, today announced that new case studies using NeutroPhase(R), its pure hypochlorous acid wound cleanser, will be presented at the 2012 Spring Symposium on Advanced Wound Care (SAWC) …

Santa Monica, CA – April 16, 2012 (Investorideas.com Newswire) Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a publicly-traded venture fund and technology incubator, is pleased to announce that its portfolio company, Sanguine BioSciences, Inc. (“Sanguine”), has received approval from the Institutional Review Board (“IRB”) to collect Biospecimen and Clinical Data from Patients diagnosed with …

DELRAY BEACH, Fla. – April 16, 2012 (Investorideas.com newswire) – PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense, today announced significant progress with the initial deployment of its FDA-cleared iglucose(TM) mobile health system for diabetes management. …

PROGRESS OF CLINICAL DEVELOPMENT VANCOUVER, BRITISH COLUMBIA – April 16, 2012 (Investorideas.com Newswire) Pacific Therapeutics Ltd. (PT.CNSX) (the “Company”) is pleased to provide an update on the progress of the clinical development of PTL-202. As previously announced the Company has engaged CRBIO of India to conduct a drug drug interaction study of PTL-202 and its …

DELRAY BEACH, Fla. – April 13, 2012 (Investorideas.com newswire) – PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense, today announced it is offering its FDA-cleared iglucose(R) mobile health system for diabetes management to rural healthcare providers, …

New York, New York April 12, 2012 – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks releases an investor podcast for biotech traders and investors with a company spotlight on a small biotech company making headway in the diabetes and obesity market with its core technology.   Sirona Biochem …

New York, New York – April 12, 2012 – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a biotech company snapshot for Sirona Biochem Corp. ( TSX-V: SBM , OTC: SRBCF, Frankfurt: ZSB), a company using arbohydrate-based molecules to develop Sodium Glucose Transporter (SGLT) inhibitors for Type 2 …

New York, New York – April 11, 2012 – Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a biotech investor spotlight for Sirona Biochem Corp . (TSX-V: SBM, OTC: SRBCF, Frankfurt: ZSB).   Sirona Biochem is a biotechnology company developing diabetes therapeutics, cancer vaccine antigens, skin depigmenting and …

DELRAY BEACH, Fla. – April 11, 2012 (Investorideas.com newswire) – PositiveID Corporation (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense, today announced it has begun taking orders of its FDA-cleared iglucose(R) mobile health system for diabetes management. Pre-orders …

Vancouver, British Columbia – April 11, 2012 (InvestorIdeas.com Newswire) Sirona Biochem Corp. ( TSX-V: SBM , OTC: SRBCF, Frankfurt: ZSB), announced today its abstract application to present a scientific poster at the 2012 Protein Engineering Summit (PEGS) has been accepted. Sirona Biochem’s scientific poster has been selected to be on display during the “Difficult to …

  QUBYX, a technology contributor to medical imaging and color management industries, has released PerfectLum Suite, a calibration and QA software to enhance and assure the quality of medical displays.     04/11/2011, Nice, France – QUBYX has announced the official release of its medical display calibration and quality assurance software PerfectLum Suite. The software, …

As its Hot Topic for April, the Medisister website for nursing professionals is asking nurses for their views on whether staffing levels in the NHS are causing issues in patient care. Medisister points to the fact that warnings about cuts in jobs and services from the RCN (Royal College of Nursing) and other bodies have …